Equity in Access to GU Clinical Trials: What Are the Factors That May Impact Toxicity and Efficacy? Are We Lacking Diversity in IO Trials? How Can We Solve Most Common Barriers?

12 views
December 7, 2020
Comments 0
Login to view comments. Click here to Login